IgA 항체합성에 대한 초유함유 TGF- β 와 bifidobacteria의 영향 평가

• 발행기관: 한국축산식품학회
• 저자명: 김평현 고준수
• 간행물 정보: 『학술대회논문집』2001년도 임시총회 및 제28차 추계학술발표회, 43~56쪽, 전체 14쪽
• 주제분류: 농수해양 > 식품과학
• 파일형태: PDF
• 발행일자: 2001.11.30

영문 초록

Colostrum contains various kinds of cytokines including TGF-β which is known to be multifunctional in immune response and act as an anti-inflammatory agent. First, we measured the amount of TGF-β in bovine and human colostrum. Expression pattern of TGF-β isotypes was dramatically different between human and bovine colostrial samples. Bovine colostrum collected on day 1 post-delivery retained 41.79×16.96ng/ml of TGF-β 1 and 108.4±78.65ng/ml of TGF-β 2 while in human, 284±124.75ng/ml of TGF-β 1 and 29.75±6.73ng/ml of TGF-β 2. Thus, TGF-β is the predominant TGF-β isotype in bovine colostrum and vice versa in human colostrum. Both TGF-β isotypes diminished significantly in human and bovine colostrum with time. Next, biological activity of colostrial samples was examined in vitro. Both human and bovine colostrum increased IgA synthesis by LPS-activated mouse spleen B cells, which is a typical effect of TGF-β on the mouse B cell differentiation. Futhermore, we found that anti-proliferative activity in MV1LU cells by colostrum samples disappeared by addition of anti-TGF-β 1 and anti-TGF-β 2 antibody. In conclusion, there are substantial amounts of biologically active TGF-β 1 and TGF-β 2 in bovine and human colostrum. The results that the colostrum can increase IgA expression has important implications since IgA is the major Ig class produced in the gastrointestinal tract. We have previously shown that the stimulatory effect of Bifidobacteria bifidum on spllen B cells was quite similar to that of LPS which is a well-known polyclonal activator for murine B cells. In the present study, we further asked whether B. bifidum regulate the synthesis of IgA by mucosal lymphoid cells present in Peyers patches (PP) and mesenteric lymph nodes (MLN). B. bifidum alone, but not C. perfringens, significantly induced overall IgA and IgM synthesis by both MLN and PP cells. This observation indicates that B. bifidum possesses a modulatory effect on the mucosal antibody production in vivo. We, therefore, investigated the mucosal antibody prodduction following peroral administration of B. bifidum to mice. Ingested B. bifidum significantly increased the numbers of Ig (IgM, IgG, and IgA) secreting cells in the culture of both MLN and spleen cells, indicating that peroally introduced B. bifidum enhances mucosal and systemic antibody response. Importantly, however, B. bifidum itself does not induce the own specific antibody responses, implying that B. bifidum do not incite any unwanted immune reaction. Subsequently, it was found that excapsulation of B. bifidum further augments the total IgA production by increasing the number of IgA-secreting cells in the culture of both MLN and spleen cells. Finally, we found that the immuno-stimulating activity of B. bifidum is due to its cell wall components but not due to any actively secreting component(s) from bacteria. Thus our data reveal that peroral administration of B. bifidum can enhance intestinal IgA production and that encapsulation of B. bifidum further reinforces the IgA production.

목차

Abstract

Ⅰ. 서론

Ⅱ. 결과 및 고찰

Ⅲ. 결론

Ⅳ. 참고문헌